|
15 Sep 2025 |
CCL Products
|
Consensus Share Price Target
|
903.85 |
951.78 |
- |
5.30 |
buy
|
|
|
|
|
07 Feb 2025
|
CCL Products
|
Keynote Capitals Ltd
|
903.85
|
1146.00
|
654.35
(38.13%)
|
26.79 |
Buy
|
|
|
Quarterly Update Q3FY25
|
|
07 Feb 2025
|
CCL Products
|
Axis Direct
|
903.85
|
730.00
|
654.35
(38.13%)
|
Target met |
Buy
|
|
|
With a 13% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 Feb 2025
|
CCL Products
|
IDBI Capital
|
903.85
|
698.00
|
654.35
(38.13%)
|
Target met |
Hold
|
|
|
|
|
28 Jan 2025
|
CCL Products
|
CD Equisearch
|
903.85
|
681.00
|
599.45
(50.78%)
|
Target met |
Accumulate
|
|
|
|
|
11 Nov 2024
|
CCL Products
|
Keynote Capitals Ltd
|
903.85
|
1222.00
|
713.05
(26.76%)
|
35.20 |
Buy
|
|
|
Quarterly Update Q2FY25
|
|
11 Nov 2024
|
CCL Products
|
BP Wealth
|
903.85
|
|
713.05
(26.76%)
|
|
Results Update
|
|
|
|
|
07 Nov 2024
|
CCL Products
|
Axis Direct
|
903.85
|
820.00
|
701.40
(28.86%)
|
Target met |
Buy
|
|
|
With a 14% upside from the CMP, we maintain our BUY rating on the stock.
|
|
07 Nov 2024
|
CCL Products
|
IDBI Capital
|
903.85
|
734.00
|
691.70
(30.67%)
|
Target met |
Hold
|
|
|
|
|
09 Sep 2024
|
CCL Products
|
Keynote Capitals Ltd
|
903.85
|
1221.00
|
747.05
(20.99%)
|
|
Buy
|
|
|
Initiating Coverage Report
|
|
09 Aug 2024
|
CCL Products
|
Axis Direct
|
903.85
|
760.00
|
659.85
(36.98%)
|
Target met |
Buy
|
|
|
With a 15% upside from the CMP, we maintain our BUY rating on the stock.
|
|
14 May 2024
|
CCL Products
|
IDBI Capital
|
903.85
|
582.00
|
563.40
(60.43%)
|
Target met |
Hold
|
|
|
|
|
14 May 2024
|
CCL Products
|
Axis Direct
|
903.85
|
670.00
|
563.40
(60.43%)
|
Target met |
Buy
|
|
|
With a 17% upside from the CMP, we maintain our BUY rating on the stock.
|
|
30 Mar 2024
|
CCL Products
|
CD Equisearch
|
903.85
|
645.00
|
586.30
(54.16%)
|
Target met |
Hold
|
|
|
|
|
07 Feb 2024
|
CCL Products
|
Axis Direct
|
903.85
|
720.00
|
667.35
(35.44%)
|
Target met |
Buy
|
|
|
With a 12% upside from the CMP, we maintain our BUY rating on the stock.
|
|
08 Nov 2023
|
CCL Products
|
BP Wealth
|
903.85
|
|
635.85
(42.15%)
|
|
Results Update
|
|
|
|
|
08 Nov 2023
|
CCL Products
|
Axis Direct
|
903.85
|
700.00
|
635.85
(42.15%)
|
Target met |
Buy
|
|
|
With an 12% upside from the CMP we maintain our BUY rating on the stock.
|
|
07 Nov 2023
|
CCL Products
|
IDBI Capital
|
903.85
|
707.00
|
625.25
(44.56%)
|
Target met |
Hold
|
|
|
|
|
18 Jul 2023
|
CCL Products
|
Axis Direct
|
903.85
|
750.00
|
620.55
(45.65%)
|
|
Buy
|
|
|
We have maintained a BUY on the stock with an unchanged TP of Rs 750/share as we roll over our estimates to Jun'25.
|
|
18 Jul 2023
|
CCL Products
|
IDBI Capital
|
903.85
|
822.00
|
620.55
(45.65%)
|
|
Buy
|
|
|
|
|
18 Jul 2023
|
CCL Products
|
StoxBox - BP Wealth
|
903.85
|
|
620.55
(45.65%)
|
|
Buy
|
|
|
CCL Products (India) Ltd. (CCLP) registered a 28.6% YoY revenue growth to Rs. 654.9 crores in Q1FY24, surpassing market expectations of Rs. 580.1 crores, led by the company maintaining its volume-driven growth trajectory in the 18-20% range with additional volumes driven by the Vietnam plant.
|